buyWeak

Matthew C Hill bought $5,475 of APYX

Chief Financial Officer at Apyx Medical Corp. 2,500 shares at an average of $2.19, traded Dec 12, 2023, filed Dec 14, 2023.

Conviction score

Value

$5,475

2,500 shares

Holdings after

2,500

change unknown

From 52-week low

+46%

low $1.49, close $2.18

From 52-week high

-71%

high $7.59, as of Dec 12, 2023

Score components

Role
CFO
+22
Trade size
$5k at market
0
Relative to holdings
First purchase: no shares before this trade
+8
Price context
71% below the 52-week high
+8
Cluster
No other insider buying within 14 days
0
Repeat buying
First buy in 90 days
0
Track record
Too few past buys to judge (0 with prices)
0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

APYXOct 12, 2026 · close 2.65

Since filing Dec 14, 2023: +10.0%SPY +70.9% · excess -61.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-23-044805, as filed. Open on EDGAR

Date	Transaction	Shares	Price	Value	Holdings after	Filed
Dec 12, 2023	POpen-market purchase Common Stock	+2,500	$2.19	$5,475	2,500	Dec 14, 2023

Related signals

Other insiders at Apyx Medical Corp and this insider’s other filings.

Score	Company	Insider	Value	Holdings	Filed
32Weak	APYXbuy Apyx Medical Corp	Matthew C Hill Chief Financial Officer	$6,030 5,336 shares	+213%	Aug 13, 2024
62Notable	APYXbuy Apyx Medical Corp	Charles D. Goodwin II Chief Executive Officer	$79k 50,000 shares	+125%	Nov 15, 2023

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.